1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events
(
- Contribution to journal › Article
- 2021
-
Mark
The novel collagen matrikine, endotrophin, is associated with mortality and cardiovascular events in patients with atherosclerosis
(
- Contribution to journal › Article
- 2020
-
Mark
The proteoglycan mimecan is associated with carotid plaque vulnerability and increased risk of future cardiovascular death
(
- Contribution to journal › Article
-
Mark
Carotid Plaque Morphology is Similar in Patients with Reduced and Normal Renal Function
(
- Contribution to journal › Article
-
Mark
Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events
(
- Contribution to journal › Article
-
Mark
Evidence for a protective role of placental growth factor in cardiovascular disease
(
- Contribution to journal › Article
- 2019
-
Mark
A biomarker of collagen type I degradation is associated with cardiovascular events and mortality in patients with atherosclerosis
(
- Contribution to journal › Article
-
Mark
Soluble TRAIL-R2 a marker of plaque cell apoptosis and cardiovascular events.
(
- Contribution to journal › Article
- 2018
-
Mark
Markers of basement membrane remodeling are associated with higher mortality in patients with known atherosclerosis
(
- Contribution to journal › Article
- 2015
-
Mark
Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice.
(
- Contribution to journal › Article